Sign in

CIK 0000072444

  • Accelerated filer
  • Smaller reporting company

Vaxart, Inc.

Sign in to watch
Ticker
VXRT
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
591212264
Phone
+1 650-550-3500
Business address
310 UTAH AVENUE, SUITE 150, SOUTH SAN FRANCISCO, CA
Former names
Aviragen Therapeutics, Inc., Biota Pharmaceuticals, Inc., NABI BIOPHARMACEUTICALS, NABI BIOPHARMACEUTICALS, NABI /DE/, NORTH AMERICAN BIOLOGICALS INC
  1. 4 Open-market sale SVP, Principal Accntng Officer sold 1,800 shares at $8.00 ($14,400)
  2. 4 Option exercise Director acquired 181,818 shares (option exercise)
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Open-market sale Director sold 10,000 shares at $8.61 ($86,109)
  12. 4 Open-market sale SVP, Principal Accntng Officer sold 1,802 shares at $8.00 ($14,416)
  13. 4/A Derivatives Options or other derivatives
  14. 4/A Derivatives Options or other derivatives
  15. 4 Open-market sale SVP, Principal Accntng Officer sold 47,555 shares at $8.00 ($380,440)
  16. 4 Open-market sale Director sold 200,000 shares at an average $6.83 ($1,366,640)
  17. 3 Insider Initial Statement of Ownership
  18. 4 Exercise or conversion Chief Scientific Officer acquired 1,006 shares (option exercise)
  19. 4 Open-market sale Director sold 150,000 shares at $6.04 ($906,450)
  20. 4 Open-market sale Director sold 333,334 shares at $6.32 ($2,108,138)

Page 7 of 28 · 550 filings